The Enterprise Value as of December 2025 (TTM) for DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) is 24.63B

According to DaShenLin Pharmaceutical Group Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 24.63B. This represents a change of 29.18% compared to the average of 19.07B of the last 4 quarters.

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) Historical Enterprise Value (quarterly & annually)

How has 603233.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of DaShenLin Pharmaceutical Group Co., Ltd. over the last ten years is 25.51B. The current 24.63B Enterprise Value has changed 9.56% with respect to the historical average. Over the past ten years (40 quarters), 603233.SS's Enterprise Value was at its highest in in the March 2021 quarter at 56.21B. The Enterprise Value was at its lowest in in the December 2015 quarter at -266349680.00.

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of DaShenLin Pharmaceutical Group Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) Average Enterprise Value

How has 603233.SS Enterprise Value performed in the past?

The current Enterprise Value of DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) Enterprise Value vs. Peers

How is 603233.SS’s Enterprise Value compared to its peers?

DaShenLin Pharmaceutical Group Co., Ltd.’s Enterprise Value is greater than Anhui Anke Biotechnology (Group) Co., Ltd. (16.19B), greater than Yunnan Botanee Bio-Technology Group Co.LTD (16.55B), greater than Inner Mongolia Furui Medical Science Co., Ltd. (17.31B), greater than Mabwell (Shanghai) Bioscience Co., Ltd. (17.50B), greater than Staidson (Beijing) BioPharmaceuticals Co., Ltd. (12.92B), greater than China Resources Double-Crane Pharmaceutical Co.,Ltd. (18.14B), greater than Autobio Diagnostics Co., Ltd. (20.50B), greater than Liaoning Cheng Da Co., Ltd. (23.11B), greater than Joincare Pharmaceutical Group Industry Co.,Ltd. (14.20B), greater than China National Medicines Corporation Ltd. (16.74B),

Build a custom stock screener for DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DaShenLin Pharmaceutical Group Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DaShenLin Pharmaceutical Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.